Percutaneous coronary intervention (PCI) of multivessel and/or left main stem disease have been shown to be potentially legitimate revascularization alternatives in appropriately selected patients. Risk stratification is an important component in guiding patients to identify the most appropriate revascularization modality (PCI or coronary artery bypass grafting [CABG]) in conjunction with the Heart Team. The aim of this paper is to give the clinician a concise overview of the important established and evolving contemporary risk models in aiding this decision-making process. Risk models, based on clinical and anatomical variables alone, the novel concept of functional anatomical risk scores, and risk models combining aspects from both clinic...
This article reviews the current risk assessment models available for patients presenting with myoca...
Coronary procedures predispose patients to adverse events. To improve our understanding of the genet...
The management of severe left main (LM) disease remains controversial and continues to evolve as new...
Risk stratification is an essential part of appropriately informing patients electing to undergo per...
Percutaneous coronary intervention of unprotected left main stem lesions has been shown to be a suit...
Percutaneous coronary intervention of unprotected left main stem lesions has been shown to be a suit...
Background—Coronary artery bypass graft (CABG) and percutaneous coronary revascularization (PCI) are...
type 2 diabetes mellitus to prompt coronary revascularization plus intensive medical therapy versus ...
Aims: When patients choose percutaneous coronary intervention (PCI) over coronary artery bypass graf...
BackgroundHeart Team (HT) and the SYNTAX Score II (SSII) have been integrated to the contemporary gu...
Aim of study: PHASE 1: To identify those clinical and simple anatomical variables that could predic...
AbstractObjectivesOur goals were to identify clinical and angiographic risk factors associated with ...
Abstract Introduction: Risk scores evaluate pre-operatory risk and present support for clinical dec...
For coronary artery disease (CAD) patients, who cannot be managed with risk factor modification and ...
The management of severe left main (LM) disease remains controversial and continues to evolve as new...
This article reviews the current risk assessment models available for patients presenting with myoca...
Coronary procedures predispose patients to adverse events. To improve our understanding of the genet...
The management of severe left main (LM) disease remains controversial and continues to evolve as new...
Risk stratification is an essential part of appropriately informing patients electing to undergo per...
Percutaneous coronary intervention of unprotected left main stem lesions has been shown to be a suit...
Percutaneous coronary intervention of unprotected left main stem lesions has been shown to be a suit...
Background—Coronary artery bypass graft (CABG) and percutaneous coronary revascularization (PCI) are...
type 2 diabetes mellitus to prompt coronary revascularization plus intensive medical therapy versus ...
Aims: When patients choose percutaneous coronary intervention (PCI) over coronary artery bypass graf...
BackgroundHeart Team (HT) and the SYNTAX Score II (SSII) have been integrated to the contemporary gu...
Aim of study: PHASE 1: To identify those clinical and simple anatomical variables that could predic...
AbstractObjectivesOur goals were to identify clinical and angiographic risk factors associated with ...
Abstract Introduction: Risk scores evaluate pre-operatory risk and present support for clinical dec...
For coronary artery disease (CAD) patients, who cannot be managed with risk factor modification and ...
The management of severe left main (LM) disease remains controversial and continues to evolve as new...
This article reviews the current risk assessment models available for patients presenting with myoca...
Coronary procedures predispose patients to adverse events. To improve our understanding of the genet...
The management of severe left main (LM) disease remains controversial and continues to evolve as new...